D-1082-2019 Class III Terminated

Recalled by Auro Pharmacies Inc. DBA Central Drugs — La Habra, CA

FDA drug recall D-1082-2019 was initiated by Auro Pharmacies Inc. DBA Central Drugs on Mar 22, 2019 and is designated Class III. Reason for recall: Failed pH Specification: product does not meet pH label claim. The recall status is terminated (terminated Feb 27, 2020). Affected quantity: 167 vials.

Recall details

Product Type
Drugs
Report Date
Apr 17, 2019
Initiation Date
Mar 22, 2019
Termination Date
Feb 27, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
167 vials

Product description

Biotin 10 mg/mL Injection, 30 mL vial, Rx only, 511 S. Harbor Blvd., Building. F, La Habra, CA 90631, 562-352-9630.

Reason for recall

Failed pH Specification: product does not meet pH label claim.

Distribution pattern

Nationwide within the United States

Code information

Lot 190205@1, expiry 08/4/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1082-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1082-2019. Report a data issue: hello@regdatalab.com.